Use of proteoliposome as a vaccine against Trypanosoma cruzi in mice

Chemistry and Physics of Lipids

Volumn 152, Issue 2, 2008, Pages 86-94

  Migliaccio, Vanessa ^a   Santos, Fabiana R ^a   Ciancaglini, Pietro ^a   Ramalho Pinto, F Juarez ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Detergent; Lipids; Membrane proteins; Proteoliposomes; Trypanosoma cruzi

Indexed keywords

ANTIBODY; CHOLESTEROL; DIPALMITOYLPHOSHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLSERINE; DODECYL SULFATE SODIUM; PHOSPHATIDYLCHOLINE; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNIZATION; IN VITRO STUDY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEOLIPOSOME; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIPARASITIC AGENTS; DETERGENTS; LIGHT; LIPIDS; LIPOSOMES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PROTEOLIPIDS; PROTOZOAN VACCINES; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

MUS; TRYPANOSOMA CRUZI;

EID: 41549136014     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2007.12.003     Document Type: Article

References (40)

1. Afrin F., Anam K., and Ali N. Induction of partial protection against Leishmania donovani by promastigote antigens in negatively charged liposomes. J. Parasitol. 86 (2000) 730-735
2. Andrews N.W., Hong K., Robbins E.S., and Nussenzweig V. Stage-specific surface antigens expressed during the morphogenesis of vertebrate forms of Trypanosoma cruzi. Exp. Parasitol. 64 (1987) 474-484
3. Araújo A.F., de Alencar B.C., Vasconcelos J.R., Hiyane M.I., Marinho C.R., Penido M.L., Boscardin S.B., Hoft D.F., Gazzinelli R.T., and Rodrigues M.M. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infect. Immun. 73 (2005) 6017-6025
4. Bhatia V., and Garg N. Current status and future prospects for a vaccine against American trypanosomiasis. Exp. Rev. Vaccines 4 (2005) 867-878
5. Brener Z., and Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114 (1997) 103-110
6. Brewer J.M., Tetley L., Richmond J., Leiw F.Y., and Alexander J. Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen. J. Immunol. 161 (1998) 4000-4007
7. Burleigh B.A., and Woolsey A.M. Cell signaling and Trypanosoma cruzi. Cell Microbiol. 4 (2002) 701-711
8. Camolezi F.L., Daghastanli K.R.P., Magalhães P.P., Pizauro J.M., and Ciancaglini P. Construction of an alkaline phosphatase-liposome system: a tool for biomineralization study. Int. J. Biochem. Cell Biol. 34 (2002) 1091-1101
9. Campos M.A., Closel M., Valente E.P., Cardoso J.E., Akira S., Alvarez-Leite J.I., Ropert C., and Gazzinelli R.T. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J. Immunol. 172 (2004) 1711-1718
10. Cevc G., and March D. Phospholipid bilayers. In: Bittar E.E. (Ed). Physical Principles and Models. Cell Biology: A Series of Monographs (1987), Wiley, New York 347-368
11. Chen Jr. P.S., Toribara T.Y., and Warner H. Microdetermination of phosphorus. Anal. Chem. 28 (1956) 1756-1758
12. Daghastanli K.R.P., Ferreira R.B., Thedei Jr. G., Maggio B., and Ciancaglini P. Lipid composition-dependent incorporation of multiple membrane proteins into liposomes. Colloids Surf. B Biointerfaces 36 (2004) 127-137
13. De Alencar B.C., Araujo A.F., Penido M.L., Gazzinelli R.T., and Rodrigues M.M. Cross-priming of long lived protective CD8(+) T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4(+) T cells. Vaccine 25 (2007) 6018-6027
14. Frank F.M., Petray P.B., Cazorla S.I., Muñoz M.C., Corral R.S., and Malchiodi E.L. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes. Vaccine 22 (2003) 77-86
15. Gazzinelli R.T., Hienry S., Wyn T., Wolf S., and Sher A. Interleukin 12 is required for the T-lymphocyte independent induction of interferon-gamma by an intracellular parasite and induced resistance in T-cell-deficient host. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6115-6119
16. Gonzalez J., Ramalho-Pinto F.J., Frevert U., Ghiso J., Tomlinson S., Scharfstein J., Corey E.J., and Nussenzweig V. Proteasome activity is required for the stage-specific transformation of a protozoan parasite. J. Exp. Med. 184 (1996) 1909-1918
17. Greaves D.R., and Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 46 (2005) 11-20
18. Guarner J., Bartlett J., Zaki S.R., Colley D.G., Grijalva M.J., and Powell M.R. Mouse model for Chagas disease: immunohistochemical distribution of different stages of Trypanosoma cruzi in tissues throughout infection. Am. J. Trop. Med. Hyg. 65 (2001) 152-158
19. Hartree E.F. Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 48 (1972) 422-427
20. Higgins G. Separation and analysis of membrane lipid components. In: Findlay J.B.C., and Evans W.H. (Eds). Biological Membranes (Practical Approach Series) (1987), IRL Press, Oxford, Washington, DC 104-137
21. Hoft D.F., Schnapp A.R., Eickhoff C.S., and Roodman S.T. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect. Immun. 68 (2000) 197-204
22. Hoft D.F., and Eickhoff C.S. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infect. Immun. 70 (2002) 6715-6725
23. Ignatius R., Mahnke K., Rivera M., Hong K., Isdell F., Steinman R.M., Pope M., and Stamatatos L. Presentation of proteins encapsulated into liposome by dendritic cells initiates CD8+ T-cell responses in vivo. Blood 96 (2000) 3505-3513
24. Kita Y., Tanaka T., Yoshida S., Ohara N., Kaneda Y., Kuwayama S., Muraki Y., Kanamaru N., Hashimoto S., Takai H., Okada C., Fukunaga Y., Sakaguchi Y., Furukawa I., Yamada K., Inoue Y., Takemoto Y., Naito M., Yamada T., Matsumoto M., McMurray D.N., Cruz E.C., Tan E.V., Abalos R.M., Burgos J.A., Gelber R., Skeiky Y., Reed S., Sakatani M., and Okada M. Novel recombinant BCG and DNA vaccination against tuberculosis in a cynomolgus monkey model. Vaccine 23 (2005) 2132-2135
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
26. Leserman L. Liposomes as protein carriers in immunology. J. Liposome Res. 14 (2004) 175-189
27. Low H.P., Santos M.A.M., Wizel B., and Tarleton R.L. Amastigote surface proteins of Trypanosoma cruzi are targets for CD81 CTL. J. Immunol. 160 (1998) 1817-1823
28. Mesa C., Leon J., Rigley K., and Fernandez L.E. Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation. Vaccine 22 (2004) 3045-3052
29. Miller M.J., Wrightsman R.A., and Manning J.E. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response. Exp. Parasitol. 84 (1996) 156-167
30. Mortara R.A., Minelli L.M., Vandekerhove F., Nussenzweig V., and Ramalho-Pinto F.J. Phosphatidylinositol-specific phospholipase C (PI-PLC) cleavage of GPI-anchored surface molecules of Trypanosoma cruzi triggers in vitro morphological reorganization of trypomastigotes. J. Eukaryot. Microbiol. 48 (2001) 27-37
31. Read S.M., and Northcote D.H. Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal. Biochem. 116 (1981) 53-64
32. Rigaud J.L. Membrane proteins: functional and structural studies using reconstituted proteoliposomes and 2-D crystals. Braz. J. Med. Biol. Res. 35 (2002) 753-766
33. Rigaud J.L., Lévy D., Mosser G., and Lambert O. Detergent removal by non-polar polystyrene beads. Eur. Biophys. J. 27 (1998) 305-319
34. Sanchez-Burgos G., Mezquita-Vega R.G., Escobedo-Ortegon J., Ramirez-Sierra M.J., Arjona-Torres A., Ouaissi A., Rodrigues M.N., and Dumonteil E. Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice. FEMS Immunol. Med. Microbiol. 50 (2007) 333-341
35. Santos H.L., and Ciancaglini P. A practical approach to the choice of a suitable detergent and optimal conditions for solubilizing a membrane protein. Biochem. Educ. 28 (2000) 178-182
36. Santos F.R., Ferraz D.B., Daghastanli K.R.P., Ramalho-Pinto F.J., and Ciancaglini P. Mimetic membrane system to carry multiple antigenic proteins from Leishmania amazonensis. J. Membr. Biol. 210 (2006) 173-181
37. Shakushiro K., Yamasaki Y., Nishikawa M., and Takakura Y. Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells. Immunology 112 (2004) 211-218
38. Silvius J.R. Solubilization and functional reconstitution of biomembrane components. Annu. Rev. Biophys. Biomol. Struct. 21 (1992) 323-348
39. Tempone A.G., Perez D., Rath S., Vilarinho A.L., Mortara R.A., and de Andrade Jr. H.F. Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine. J. Antimicrob. Chemother. 54 (2004) 60-68
40. Yotsumoto S., Kakiuchi T., and Aramaki Y. Enhancement of IFN-γ production for Th1-cell therapy using negatively charged liposomes containing phosphatidylserine. Vaccine 25 (2007) 5256-5262